NUMARK HEAD LICE TREATMENT is a brand name for Permethrin. The medicine, its uses, side effects and dosage are the same regardless of brand.
Used for: Numark Head Lice Treatment 1% w/w Cutaneous Emulsion is intended for the treatment of head lice (pediculus humanus capitis) infestations.
Verbatim from this product's MHRA label. Tap a section to expand.
2 Posology & Method of Administration: Numark Head Lice Treatment 1% w/w Cutaneous Emulsion is applied topically and is for external use only.
Adults and children over 3 years:
The lotion should be used after the hair has been washed with a mild non-conditioning and non-medicated shampoo and then towel dried. The bottle should be shaken thoroughly and the hair and scalp should be saturated with the lotion, with particular attention given to the areas at the back of the neck and behind the ears.
The lotion should be left on for 10 minutes. Thereafter, the hair should be rinsed thoroughly with water and combed with an ordinary comb. The hair should then be rinsed again, combed with a fine toothed comb (provided with the pack) to remove dead lice and eggs, and dried in the usual way.
One bottle of Numark Head Lice Treatment 1% w/w Cutaneous Emulsion is usually sufficient to treat one person with shoulder length hair of average thickness, a little more may be required if the person’s hair is especially thick or long.
It is very unlikely that more than two bottles will be required per application. If after 7-10 days of treatment with permethrin living lice are found, treatment with permethrin should be repeated. If after 14-20 days infestation is still active treatment with an alternative product should be considered.
Children:
Not recommended for children under 3 years except on advice of a doctor.
Elderly:
As for adults.
Side effects are not common with Numark Head Lice Treatment 1% w/w Cutaneous Emulsion and if they occur they are usually mild and indistinguishable from the head lice infestation itself. Occasionally, skin irritation, redness or rash may occur.
If severe or prolonged signs and symptoms of scalp irritation, skin discomfort, or other undesirable effects occur in association with the use of Numark Head Lice Treatment 1% w/w Cutaneous Emulsion it should be brought to the attention of a doctor or pharmacist.
Post-marketing Data:
Adverse drug reactions (ADRs) identified during post-marketing experience with permethrin are included in table below.
The frequencies are provided according to the following convention:
Very common (1/10); Common (1/100 and < 1/10); Uncommon (1/1,000 and < 1/100); Rare (1/10,000, <1/1,000); Very rare (<1/10,000); Not known (cannot be estimated from the available data). System Organ Classes (SOC) Frequency Adverse Drug Reaction Nervous system Not known Sensations on the skin (paraesthesia) such as tingling, pricking, skin burning sensation Alopecia Reporting of suspected adverse reactions: Reporting suspected adverse reactions after authorisation of the medicinal product is important.
It allows continued monitoring of the benefit/risk balance of the medicinal product. uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store
Numark Head Lice Treatment 1% w/w Cutaneous Emulsion is contraindicated in patients with a known sensitivity to the product, its components and other pyrethroids or pyrethrins. 2 Special Warnings and Special Precautions for use: The active ingredient and the product are not known to be irritating to the eyes.
However, if the product comes into contact with the eyes, rinse immediately with plenty of water. g. contact dermatitis) and Propylene glycol (E 1520) may cause skin irritation. Do not use this medicine in babies less than 4 weeks old with open wounds or large areas of broken or damaged skin (such as burns) without talking to your doctor or pharmacist.
In the case of hypersensitivity to chrysanthemums or other compositae, treatment should only be given if strictly indicated. In such cases treatment should be switched to a chemically different agent. Nursing or care staff who routinely use the product should wear gloves in order to avoid potential irritation to the hands.
The effect of this product on artificial hair dyes and perms has not been determined. Although complaints are extremely rare, it is recommended to apply the product to a small section of hair first, before treating the entire scalp.
Numark Head Lice Treatment 1% w/w Cutaneous Emulsion is for external use only Paediatric population Only limited experience is available with Numark Head Lice Treatment 1% w/w Cutaneous Emulsion in children aged over 6 months up to 3 years.
Therefore, treatment must be performed only under close specialist supervision in this age group. Not to be used by persons known to be sensitive to the ingredients. Numark Head Lice Treatment 1% w/w Cutaneous Emulsion may be used as normal in asthmatics, however contact your doctor or pharmacist before commencing treatment if you have any particular concerns.
Not medical advice. Always read the patient information leaflet and follow your prescriber or pharmacist.
Other brands of Permethrin in United Kingdom.
Know a brand we are missing in United Kingdom? Suggest a brand →
Brand names are compiled from public regulatory records for active-ingredient mapping only. Drugvu is not affiliated with any manufacturer. This is not medical advice.
Permethrin is not affected by chlorine in swimming baths, so normal swimming activities may continue after use. As for other products used for the treatment of head lice, resistance can occur. After one week the result of the treatment should be checked.
If living lice are still found,the treatment can be repeated with the same product. If, after 14 days, it is certain that the infestation is still active, it is best to switch to another active product. Treatment failure and resistance development Varying clinical success rates to permethrin in the treatment of head lice have been observed geographically and over time.
Factors associated with treatment failure include incorrect dosing or administration errors, lack of concurrent treatment of household members, and re-infestation from community contacts. Furthermore, resistance to permethrin has been detected.
However, no clear correlation could be established between lack of efficacy and mutations known to confer pyrethroid resistance. Official guidance on the appropriate use of pediculicide agents should be considered